...
首页> 外文期刊>The Journal of law, medicine & ethics: a journal of the American Society of Law, Medicine & Ethics >Moral gridlock: Conceptual barriers to no-fault compensation for injured research subjects
【24h】

Moral gridlock: Conceptual barriers to no-fault compensation for injured research subjects

机译:道德僵局:为受伤的研究对象提供无过错赔偿的概念性障碍

获取原文
获取原文并翻译 | 示例
           

摘要

The federal regulations that govern biomedical research, most notably those enshrined in the Common Rule, express a protectionist ethos aimed at safeguarding subjects of human experimentation from the potential harms of research participation. In at least one critical way, however, the regulations have always fallen short of this promise: if a subject suffers a research-related injury, then neither the investigator nor the sponsor has any legal obligation under the regulations to care for or compensate the subject. Because very few subjects with research-related injuries can meet the financial or evidentiary requirements associated with a successful legal claim to recover the costs associated with their injuries, most injured subjects must shoulder the burden of those expenses alone. For 40 years, national advisory panels have concluded that this result is out of step with the Common Rule's otherwise protectionist promise. When the Department of Health and Human Services released an Advance Notice of Proposed Rulemaking (ANPRM) in 2011, suggesting potential changes to the Common Rule, the time seemed ripe to address research-related injuries. The ANPRM, however, makes no mention of compensation for research-related injuries, and the federal government once again seems poised to stop short of addressing what has arguably become the most longstanding, frequent, and consistent plea for regulatory reform of research: protections for injured subjects. This article asks why, despite decades of federal-level panels recommending no-fault compensation for research-related injuries, the United States has so strongly resisted change. I suggest that a central reason for our current impasse is that, despite consensus among federal advisory committees that there is an obligation to compensate injured subjects, the committees have not coalesced around a moral justification for that duty. Although multiple justifications can support and even strengthen a single ethical obligation, the reverse has occurred in this context. I demonstrate that the committees' articulation of multiple ethical principles - including humanitarianism, professional beneficence, and compensatory justice - results in incongruent obligations that favor different kinds of compensation systems. This outcome, which I call "moral gridlock," makes it extremely difficult to determine what kind of compensation scheme to implement. Recognizing that each moral argument for compensation creates a slightly different trajectory is, however, an important first step in moving toward a more systematic approach to compensating injured research subjects.
机译:管理生物医学研究的联邦法规,特别是《通用规则》中所载的法规,表达了一种保护主义的精神,旨在保护人类实验对象免受研究参与的潜在危害。但是,至少在一种关键的方式上,法规始终未能兑现这一承诺:如果受试者遭受与研究相关的伤害,那么研究人员和申办者均没有法规规定的任何照护或补偿受试者的法律义务。 。由于很少有与研究相关的受伤的受试者能够满足与成功的法律要求有关的经济或证据要求,以追回与受伤有关的费用,因此大多数受伤的受试者必须独自承担这些费用的负担。 40年来,国家咨询小组得出的结论是,这一结果与《通用规则》原本以贸易保护主义的承诺背道而驰。当卫生与公共服务部于2011年发布《拟议规则制定的预先通知》(ANPRM),建议对《通用规则》进行潜在更改时,似乎已经到了解决与研究相关的伤害的时机。但是,ANPRM没有提及与研究相关的伤害的赔偿,而且联邦政府似乎也准备再次停止解决可以说已成为研究监管改革最长期,最频繁和始终如一的呼吁:受伤的受试者。本文提出了一个理由,尽管数十年来联邦级专家组建议对研究相关伤害不予赔偿,但美国却如此坚决抵制变革。我认为,造成当前僵局的主要原因是,尽管联邦咨询委员会达成共识,即有义务赔偿受伤的受害人,但委员会并没有围绕这项职责的道义辩护。尽管有多种理由可以支持甚至加强一项道德义务,但在这种情况下却发生了相反的情况。我证明,委员会对多种道德原则的明确表述-包括人道主义,专业救济和补偿性司法-导致义务不一致,有利于各种赔偿制度。这个结果,我称之为“道德僵局”,使得很难确定实施哪种补偿方案。但是,认识到每种道德上的赔偿论点都会产生稍微不同的轨迹,这是迈向采用更系统的方法来赔偿受伤的研究对象的重要的第一步。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号